YANCOPOULOS GEORGE (President and CSO) exercised options at REGENERON PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/11/2025ACC: 0001226690-25-000005
DirectorOfficer· President and CSO
Since Nov 2015
-131.87K
Net shares
Net seller
$92.51M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
146.81K acquired · 278.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+146.81K
Price / share
$555.67
Trade value
$81.58M
% of position
49.7%
12/9/2025
295.52K→442.33K
Common Stock
Direct
Shares
−131.87K
Price / share
$701.51
Trade value
$92.51M
% of position
29.8%
12/9/2025
442.33K→310.46K
Total
Net shares
+14.94K
Net value
-$10.93M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | M · Option Exercise | +146.81K | $555.67 | $81.58M | 49.7% | 295.52K | 442.33K |
| Common Stock Direct | 12/9/2025 | F · Tax Withholding | −131.87K | $701.51 | $92.51M | 29.8% | 442.33K | 310.46K |
| Total | +14.94K | -$10.93M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
146.81K shares
Shares
−146.81K
Strike price
555.67
Held after
0.00
Exercisable
—
12/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock146.81K shares | 12/9/2025 | M · Option Exercise | −146.81K | 555.67 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)7
Common Stock
IndirectShares owned71.49K
Common Stock
IndirectShares owned5.96K
Common Stock
IndirectShares owned200K
Common Stock
IndirectShares owned200K
Common Stock
IndirectShares owned180K
Common Stock
IndirectShares owned56.05K
Common Stock
IndirectShares owned101.99K
Total
815.49K indirect815.49K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 71.49K | Indirect |
| Common Stock | 5.96K | Indirect |
| Common Stock | 200K | Indirect |
| Common Stock | 200K | Indirect |
| Common Stock | 180K | Indirect |
| Common Stock | 56.05K | Indirect |
| Common Stock | 101.99K | Indirect |
| Total | 815.49K | 815.49K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported